Primary Record
cephradine
- In stock
- 7,276 g
- Purity
- 98.4 %
- CAS
- 38821-53-3
Compound Identifiers & Properties
- CAS
- 38821-53-3
- PubChem CID
- 38103
- SMILES
- CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O
- Canonical SMILES
- CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1
Names & Synonyms
- cephradine
- Cefradine
- Cephradin
- Anspor
- Sefril
- Velosef
- Cefradina
- Eskacef
- Cefradinum
- Cefradin
- 38821-53-3
- Megacef
- Cekodin
- Velocef
- cefradex
- Megace f
- Ecosporina
- Eskasporin
- Maxisporin
- Cefradal
- Dicefalin
- Eskefrin
- Norbitina
- Escacef
- Infexin
- Veracef
- Cefrag
- Cefril
- Cephradine anhydrous
- Cefro
- Cephradine hydrate
- Cefradine [INN]
- Cefradine CRS
- Cefradinecarbonate
- Cephradine (USP)
- Velosef (TN)
- Anspor (TN)
- Cefradinum [INN-Latin]
- Cephradine [USAN:BAN]
- Cefradina [INN-Spanish]
- Cephradine monohydrate
- Cephradine (anhydrous)
- Cefradine (JAN/INN)
- CEFRADINE HYDRATE
- CEPHRADINE SODIUM
- Dihydrate, Cephradine
- Cephradine (Standard)
- 9YA6SX5S4D
- CEFRADINE [JAN]
- CEPHRADINE [MI]
- UNII-9YA6SX5S4D
- VELOSEF '125'
- VELOSEF '250'
- VELOSEF '500'
- C16H19N3O4S
- AC1Q6LOA
- RefChem:575139
- UNII-FUC0D71IZN
- CEPHRADINE [HSDB]
- CHEBI:3547
- DTXSID4022785
- SQ 11436
- CEFRADINE [MART.]
- D06KKS
- Epitope ID:116210
- HSDB 3216
- CEFRADINE [WHO-DD]
- Cephradine, unspecified hydrate
- SCHEMBL3244
- SKF D 39304
- VELOSEF 125
- VELOSEF 250
- VELOSEF 500
- VELOSEF'125
- VELOSEF'250
- VELOSEF'500
- DTXCID002785
- CHEMBL1604
- DivK1c_000739
- SQ-11436
- EINECS 254-137-8
- RDLPVSKMFDYCOR-UEKVPHQBSA-N
- SK&F D-39304
- AC1L1Z38
- AMY500
- Cephradine(sterile/non-sterile)
- F1BC02I72W
- GTPL4830
- CEFRADINE [EP MONOGRAPH]
- NSC-756672
- ERK5-3N16
- HMS502E21
- HY-B1156R
- KBio1_000739
- BRN 6075388
- J01DA31
- MFCD00865048
- NINDS_000739
- SK&F-D-39304
- BCPP000291
- SQ 22022 [DIHYDRATE]
- SQ-22022
- SK-D-39304
- ADA97570
- CID38103
- HY-B1156
- MSK12003
- SK&FD-39304
- ZINC3830515
- Tox21_113488
- BBF-00762
- BDBM50370585
- C16-H19-N3-O4-S
- EBC-14619
- NCGC00183036-01
- Non-Stoichiometric Hydrate Cephradine
- s4671
- Cefradine for peak identification CRS
- AKOS015961130
- Cephradine, Non Stoichiometric Hydrate
- Tox21_113488_1
- AA44691
- AC-1409
- BCP9000506
- CCG-208520
- CS-4608
- CS-O-30547
- DB01333
- J3.185B
- NSC 756672
- SQ11436
- IDI1_000739
- NCGC00183036-02
- NCGC00263658-01
- AN-14970
- AS-75158
- BC205857
- SC-13473
- 7-(D-2-Amino-2-(1,4-cyclohexadienyl)acetamide)desacetoxycephalosporanicacid
- (6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- CAS-38821-53-3
- LS-149955
- C2988
- (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- C06897
- C74975
- D00264
- EN300-6479201
- 821C533
- A824290
- (6R,7R)-7-[(2R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 7-(D-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-caboxylic acid
- Q2734674
- BRD-K13797099-001-01-1
- (6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-amino-1,4-cyclohexadien-1-ylacetyl]amino]-3-methyl-8-oxo-,(6R,7R)-
- Z2235811518
- Cefradine, European Pharmacopoeia (EP) Reference Standard
- (7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 75975-70-1
- (6R,7R)-7-(((2R)-2-AMINO-2-CYCLOHEXA-1,4-DIEN-1-YLACETYL)AMINO)-3-METHYL-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID
- (6R,7R)-7-((R)-2-Amino-2-(cyclohexa-1,4-dien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-yl-acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 58456-86-3
- 7beta-[(2R)-2-(cyclohexa-1,4-dienyl)-2-phenylacetamido]-3-methyl-3,4-didehydrocepham-4-carboxylic acid
- CED
- (6R- -( -3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
- 7-[D-2-amino-2-(1,4-cyclohexadienyl)acetamido]desacetoxycephalosporanic acid
- Cefradine for peak identification, European Pharmacopoeia (EP) Reference Standard
- (6R)-7alpha-[[(R)-Amino(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-((2R)-2-amino-2-(cyclohexa-1,4-dien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- (6R,7R)-7-((R)-2-Amino-2-(cyclohexa-1,4-dien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
- (6R,7R)-7-((R)-2-Amino-2-(Cyclohexa-1,4-Dien-1-Yl)Acetamido)-3-Methyl-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-3-Ene-2-Carboxylic Acid
- (6R,7R)-7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
- (6R,7R)-7-[[(R)-Amino(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-{[(2R)-2-Amino-2-(cyclohexa-1,4-dien-1-yl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7alpha-[[(R)-Amino(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 254-137-8
- 38821-53-3 [anhydrous], 58456-86-3 [dihydrate], 31828-50-9 [non-stoichiometric hydrate]
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methyl-8-oxo-, (6R-(6-alpha,7-beta(R*)))-
- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((AMINO-1,4-CYCLOHEXADIEN-1-YLACETYL)AMINO)-3-METHYL-8-OXO-, (6R-(6.ALPHA.,7.BETA.(R*)))-
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(2-amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-, hydrate, D-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(amino-1,4-cyclohexadien-1-ylacetyl)amino]-3-methyl-8-oxo-, [6R-[6.alpha.,7.beta.(R*)]]-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(amino-1,4-cyclohexadien-1-ylacetyl)amino]-3-methyl-8-oxo-, monohydrate, [6R-[6.alpha.,7.beta.(R*)]]-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-,(6R,7R)-
- Cefradine; (6R,7R)-7-[[(2R)-amino(cyclohexa-1,4-dienyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cephradine; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino-1,4-cyclohexadien-1-ylacetyl]amino]-3-methyl-8-oxo-, (6R,7R)- (9CI); Anspor; Cefradex; Cefradin; Cefrag; Cefro; Celex; Cephradin; Cesporan; Dimacef; Easkacef; Ecosporina; Eskacef; Lenzacef; Lisacef; Megacef; SQ 11436; Samedrin; Sefril; Velocef; Velosef; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-, (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(amino-1,4-cyclohexadien-1-ylacetyl)amino]-3-methyl-8-oxo-, [6R-[6alpha,7beta(R*)]]-; 7-[D-alpha-Amino-(1,4-cyclohexadienyl)acetamide]-3-desacetoxycephalosphoranic acid; Cephalexin related; CCI 9420; 5-Thia-1-azabicyclo[4.2.0]oc
- RAD